0001209191-15-006536.txt : 20150126 0001209191-15-006536.hdr.sgml : 20150126 20150126165742 ACCESSION NUMBER: 0001209191-15-006536 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150123 FILED AS OF DATE: 20150126 DATE AS OF CHANGE: 20150126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daly James M CENTRAL INDEX KEY: 0001560782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 15549161 MAIL ADDRESS: STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336 CITY: WILMINGTON STATE: DE ZIP: 19880 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-01-23 0 0000879169 INCYTE CORP INCY 0001560782 Daly James M 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP, Chief Commercial Officer Common Stock 2015-01-23 4 M 0 7731 16.62 A 11252 D Common Stock 2015-01-23 4 M 0 601 16.62 A 11853 D Common Stock 2015-01-23 4 M 0 2777 18.32 A 14630 D Common Stock 2015-01-23 4 S 0 11109 77.68 D 3521 D Non-Qualified Stock Option (right to buy) 16.62 2015-01-23 4 M 0 7731 0.00 D 2019-10-21 Common Stock 7731 69587 D Non-Qualified Stock Option (right to buy) 16.62 2015-01-23 4 M 0 601 0.00 D 2019-10-21 Common Stock 601 5415 D Non-Qualified Stock Option (right to buy) 18.32 2015-01-23 4 M 0 2777 0.00 D 2020-02-08 Common Stock 2777 30655 D Represents weighted average sale price. Actual sale prices ranged from $76.99 - $78.10. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. Beginning October 22, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ James M. Daly 2015-01-26